We studied. by ligand binding methods, the two adenosine receptors, Al and A2, in rat and pig cere bral microvessels and pig choroid plexus. Ligand binding to cerebral microvessels was compared with that to membranes of the cerebral cortex.
Increasing evidence suggests that adenosine has an important role in the regulation of the brain cir culation (Winn et aI., 1981) . Both in vivo and in vitro studies demonstrate that adenosine and some of its stable analogues dilate and/or relax larger ce rebral blood vessels (Wahl and Kuschinsky, 1976; Hardebo and Edvinsson, 1979; Heistad et aI., 1981; Edvinsson and Fredholm, 1983) . Although direct physiological effects of adenosine have not been demonstrated in brain microvessels in vivo, several groups have shown that it and its analogues en hance adenylate cyclase activity in isolated cere bral microvessels (Huang and Drummond, 1979; Palmer and Ghai, 1982; Schutz et aI., 1982; Huang and Rorstad, 1983; Shimizu, 1983) . We reasoned that if adenosine has any effects on the brain mi crocirculation, then recognition or "receptor" sites for adenosine must exist on cerebral microvessels to mediate them.
It is generally accepted that adenosine acts on the central nervous system via two receptor sub types, Al and A2 (Daly, 1982; Murphy and Snyder, 1982) . AI-receptor stimulation inhibits cyclic AMP formation, while A2-receptor agonists increase ade nylate cyclase activity and cyclic AMP synthesis (Daly et aI., 1981 (Daly et aI., , 1983 . Each of these adenosine receptor subtypes shows a rank order potency to various adenosine analogues and to methyl xanthines. In this study, we investigated Ac and A2-receptors of cerebral microvessels and choroid plexus by direct ligand binding techniques, using [3H]cyclohexyladenosine ([3H]CHA) and r3H]L phenylisopropyladenosine ([3H]L-PIA) as ligands for the AI-receptor (Bruns et aI., 1980; Murphy and Snyder, 1982) and [3H]5'-N-ethylcarboxamide adenosine ([3H]NECA) as a ligand for the A2-re ceptor (Yeung and Green, 1984) . We find that cere bral microvessels and choroid plexus exhibit spe cific binding sites for A2-receptors, but have no ap preciable AI-receptor sites. We also provide evidence that confers biological relevance to these binding studies. Part of these results was presented as an abstract (Kalaria and Harik, 1984) .
MATERIALS AND METHODS

Preparation o f cerebral micro vessels
Microvessels were prepared from cerebral cortical mantles of rats and pigs. Male Wistar rats (200-300 g) were killed by decapitation. The brains were quickly re moved and dissected free of meninges and choroid plexus. Cortical mantles from 4-10 rats were pooled to gether. Pig brains were obtained from adult pigs of either sex immediately after exsanguination at a local slaughter house. Their cortical mantles were freed of meninges and choroid plexus and transported to the laboratory in cold 5 mM N-2-hydroxyethylpiperazine-N' -2-ethanesulfonic acid-Ringer's buffer solution, pH 7.4. Microvessels were obtained from pooled rat cortical mantles or from cortical mantles of one pig by bulk separation as described pre viously (Harik et aI., 1985) . Purity of the cerebral micro vessel preparations was assessed by microscopy and bio chemically, as previously detailed (Harik et aI., 198 1. 1985; Dick et aI., 1984) .
Preparation o f tissues f or radioligand binding studies
Microvessels, cerebral cortex, and choroid plexus were homogenized in 50 mM Tr is buffer, pH 7.4, con taining 1 mM ethylenediaminetetraacetate (EDTA), by a lO-s burst of a Brinkmann polytron at a setting of 6. Ho mogenates were centrifuged at 48,000 g for 10 min at 0-4°C, and the pellet obtained was washed twice by sus pension in the same buffer and centrifugation. The washed pellets, representing particulate fractions of the various tissues under study, were resuspended in the same Tr is buffer to a concentration of � I mg tissue pro tein/m\. Adenosine deaminase (calf intestinal mucosa; Sigma) was added to the suspension at a final concentra tion of 5 U/ml, and the mixture was incubated at 37°C for 15 min to metabolize endogenous adenosine. The incuba tion was stopped by dilution with ice-cold Tr is buffer containing I mM EDTA, and the pellets were washed once by centrifugation and resuspended in the same volume of Tr is buffer and used for ligand binding studies.
CHA and L-PIA binding
The binding of [3H)CHA or r3H)L-PIA to tissue particu late fractions was performed at noc for 2 h in a reaction mixture (0.1 ml) that contained 50-150 ILg of tissue pro tein, varying concentrations of PH)CHA or [3H)L-PIA (specific activities 25 and 49 Ci/mmol, respectively; New England Nuclear), in the presence or absence of unla beled agonists and antagonists as required for the partic ular experiment. The reaction was terminated by dilution with 4 ml of ice-cold Tr is buffer and filtration under re duced pressure on GF/B filters. The filters were washed three times with 4 ml of cold buffer and assayed for their 3H content by liquid scintillation at �45% efficiency. Spe cific binding was defined as the difference between total binding in the absence of unlabeled agonists or antago nists and nonspecific binding in the presence of 20 ILM unlabeled CHA or L-PIA. Similar results for nonspecific binding were obtained with 100 ILM 2-chloroadenosine (2-CA). Nonspecific PH)CHA or [3H]L-PIA binding to particulate fractions of the cerebral cortex did not exceed 20% of total binding at CHA or L-PIA concentrations as high as 15 nM. In a typical experiment, total and nonspe cific radioactivity were bound to cerebral cortex particu late fraction (90 ILg protein) 2,14 1 and 308 dpm, respec tively, at 8 nM [3H)CHA.
J Cereb Blood Flow Metab. Vol. 6. No.4, 1986 NECA binding A2-receptors were studied by [3H)NECA binding. Be cause NECA binds to both AI-and A2-receptors (Bruns et aL, 1984; Yeung and Green, 1984) , it was imperative that Acreceptors be occupied or inactivated to prevent [3H]NECA from interacting with them. To achieve this, 100 nM unlabeled CHA was added to the incubation me dium (Bruns et aI., 1984) . In some experiments, the re sults of PH)NECA binding in the presence of 100 nM CHA were compared with those obtained after treatment of tissue particulate fractions with 3 mM N-ethylmale imide (NEM), as described by Yeung and Green (1984) who reported that such treatment with NEM selectively inactivates AI binding sites.
[3H]NECA binding was performed by incubating 50-150 ILg of tissue protein with varying concentrations of [3H]NECA (specific activity 30 Ci/mmol; New En gland Nuclear) at 22°C for 30 min. Binding was termi nated by dilution with cold buffer and rapid filtration under reduced pressure through Whatman GF/B filters. The washing and filtration step did not exceed 15 s. The radioactivity retained by the filters after three washes with 4 ml of buffer was assayed by liquid scintillation at �45% efficiency. Nonspecific binding was estimated in parallel incubations containing unlabeled NECA or L-PIA, both at a concentration of 200 ILM. Specific binding was calculated by subtracting nonspecific binding from total binding. Nonspecific binding increased linearly with [3H]NECA concentrations, reaching �50% of total binding at llLM [3H]NECA. In a typical experiment using 80 ILg of microvessel protein and 80 nM PH]NECA, total binding was 2,643 dpm and nonspecific binding was 882 and 1,077 dpm when unlabeled NECA and L-PIA were used, respectively. Cerebral cortex preparations gave similar values.
Because of concerns regarding the validity of results of NECA binding obtained by filtration (Yeung and Green, 1984) , we compared the results obtained by filtration with those from parallel studies where the bound and unbound fractions of NECA were separated by rapid centrifuga tion. The results of the two methods were comparable.
Adenylate cyclase and protein assays
Adenylate cyclase activity was assayed in samples of cerebral microvessels by the method of Brooker et al. (1979) . Broken cell preparations of cerebral micro vessels, previously treated with adenosine deaminase (1.5 U/ml, 30 min at 22°C), were obtained by homogeni zation with a Brinkmann polytron at a setting of 6 for 10 s in 50 mM Tr is buffer, pH 7.4.
Protein concentration of tissue suspensions was as sayed by the method of Lowry et a\. (195 1) using bovine serum albumin as standard.
Materials 5' -N-Cyclopropylcarboxamide adenosine (NCPCA) was generously donated by Dr. H. Stein from Abbott Laboratories. L-PIA was purchased from Boehringer. Unlabeled NECA was generously donated by Dr. M. Anand-Srivastava (Montreal, Canada) and by Dr. N. Cu sack (London, U.K.). Other unlabeled agonists and an tagonists of adenosine were purchased from Sigma. All adenosine analogues and methylxanthines were dissolved in aqueous buffers except L-PIA and 8-phenyltheophyl line (8-PT), which were initially dissolved (10-100 mM) in dimethylsulfoxide.
Analysis of data
The dissociation constant of binding (Kd) and maximal binding (Bmax) were calculated from Scatchard plots (1949) . These plots were analyzed for the best fit by the LIGAND curve-fitting program of Munson and Rodbard (1980) . Displacement of 3H-ligands by unlabeled agonists and antagonists was subjected to Hill analysis (Bennett and Yamamura, 1985) . ICso values were estimated from the displacement curves. Statistical significance was de termined by Student's t test (unpaired, two tailed). Sig nificance was accepted at p < 0.05.
RESULTS
The purity of microvessels was assessed by mi croscopy. The preparation consists of segments of microvessels (capillaries, arterioles, and venules) that ranged from 5 to 30 fLm in diameter, with the majority being < 1 0 fLm in diameter. Microvessels that were > 15 fLm in diameter often had smooth muscles in their walls, but we estimate that such larger microvessels did not contribute> 15% of the preparation. Figure I is a representative photomi crograph of the microvessels. In some experiments, the purity of the microvessels was also assessed biochemically by measuring the activity of -y-glu tamyl transpeptidase, which is enriched in brain capillary endothelial cells (Albert et aI. , 1966) , and by estimating quinuclidinyl benzyl ate specific binding, which is low or absent in cerebral micro vessels (Harik et aI., 1981) . The purity of micro vessels was consistent with previous reports from our laboratory, with the estimated contamination by neural and glial elements and by erythrocytes trapped within microvessels not exceeding 5% in rat preparations and 10% in the pig.
[3H]CHA binding to particulate fractions of pig and rat cerebral cortex was specific and saturable. An example of the saturability of binding is pre sented in Fig. 2 . Scatchard plots of the binding re sults revealed a linear relationship, indicating a single class of binding sites (Fig. 2, inset) . How ever, specific binding of [3H]CHA to rat and pig ce rebral microvessels and to pig choroid plexus was low, amounting to �5 and 15% of the Bmax of rat and pig cerebral cortex, respectively (Table 1 ; Fig.  2 ). Binding of [3H]L-PIA to pig microvessels and cerebral membranes also exhibited marked dis parity ( Table J) . Similar results showing very low specific binding of [3H]CHA to canine cerebral mi crovessels were also obtained in two instances (re sults not shown).
Specific [3H]NECA binding to particulate frac tions of microvessels and cerebral cortex was satu rable, whether unlabeled NECA or L-PIA was used to define nonspecific binding ( Fig. 3 ). However, Scatchard analysis of specific [3H]NECA binding to microvessels and cortex preparations gave curvi linear plots when unlabeled NECA was used (Fig. 3, inset) . Analysis of these plots using the LIGAND curve-fitting program (Munson and Rodbard, 1980) indicated that the best fit for the data was a two-site model, high-affinity and low-affinity sites. In pig cerebral microvessels, the Kd and Bmax for the high- The amount of specific binding to cerebral microvessels was �10% of that of the cerebral cortex, which did not allow rig orous quantitative analysis. Dissociation constant (Kd) and maximal binding (8m.xl for the cortex were 2.5 nM and 524 fmol/mg protein, respectively.
affinity site were 251 ± 47 nM and 1.82 ± 0.20 pmollmg protein, respectively, while the Kd and Bmax for the low-affinity site were 1.96 ± 0.27 f-LM and 5.29 ± 0.65 pmollmg protein, respectively (mean ± SEM of three to five observations). Simi larly, in rat cerebral microvessels, the Kd and Bmax results were 123 ± 23 nM and 1.11 ± 0.18 pmol/mg protein for the high-affinity site and 0.57 ± 0.15 f-LM and 2.64 ± 0.82 pmol/mg protein for the 10w affinity binding site, respectively. Similar values were also obtained within each species for prepara tions of the cerebral cortex. Different results were obtained when 200 f-LM L-PIA was used to define the nonspecific binding of [3H]NECA than when 200 f-LM unlabeled NECA was used (Fig. 3) . These differences were minimal at low [3H]NECA concentrations, but became ob vious at higher concentrations of the ligand. The Scatchard plot now was linear (Fig. 3, inset) , indi cating one class of binding sites with a Kd of 355 ± 45 nM and a Bmax of 1.32 ± 0.09 pmol/mg protein for pig cerebral microvessels (mean ± SEM of three observations). Our findings agree with those of Yeung and Green (1984) and indicate that L-PIA is useful for masking the low-affinity NECA binding sites, which appear to be ubiquitous in the brain . The Bmax and Kd of the high-affinity [3H]NECA binding sites were compa rable whether unlabeled NECA or L-PIA was used to define nonspecific binding. Because of our in terest in these high-affinity binding sites, all subse quent studies used one concentration of [3H]NECA (�100 nM), and nonspecific binding was defined in the presence of 200 f-LM L-PIA (Tables 2-4) .
NECA binding in the presence of 100 nM CHA was similar in microvessels, choroid plexus, and cerebral cortex in both pig and rat (Table 2) . NEM treatment caused a �20% decrease in specific NECA binding when compared with results ob tained in the presence of 100 nM CHA. The differ ence may have been due to failure of 100 nM CHA to occupy all AI-receptor sites or the damage of some Az-receptors by NEM treatment. However, because microvessels and choroid plexus, unlike cerebral cortex, have low CHA binding, specific NECA binding to microvessels and choroid plexus preparations in the presence and absence of 100 nM CHA yielded similar results (Table 2) . Also, we found that NECA binding to rat and pig erythro cytes was <3% of that of the cerebral cortex. Thus, the contribution of erythrocytes that are trapped within the lumen of microvessels to NECA binding in microvessel preparations is negligible. GTP and its synthetic analogue, 5'-guanylylimi dodiphosphate [Gpp(NH)p], had no discernible ef fects on N ECA binding (Table 3 ). In fact, Gpp(NH)p in concentrations as high as 0.1 mM had no effect on NECA binding at various concentra tions of the ligand (results not shown). Mg 2 + with and without Gpp(NH)p inhibited specific NECA binding to cortical but not to microvessel mem branes (Table 3) . Also, heating to 100°C for 10 min, sonication, and treatment of tissues with 0. 5% Triton X-lOO all abolished specific NECA binding to cerebral microvessels and cerebral cortex. Displacement of [3H]NECA binding by unlabeled adenosine analogues and methylxanthines, agonists and antagonists of adenosine receptors, was as sessed (Table 4 ). The rank order for the displace ment of [3H]NECA from its specific binding sites on cerebral microvessels by adenosine analogues was as follows: NECA > NCPCA > 2-CA > L-PIA > CHA. NECA and NCPCA were one to two orders of magnitude more potent in displacing [3H]NECA from cerebral microvessels than the other compounds. The rank order for [3H]NECA displacement of methylxanthines was 3-isobutyl-l methyl xanthine > 8-PT > theophylline> caffeine.
Cyclic AMP generation by cerebral microvessels was stimulated by supramaximal concentrations of NECA and 2-CA but not by CHA (results not shown). These results are consistent with the con- clusions derived from the binding studies and with previous reports (Huang and Drummond, 1979; Palmer and Ghai, 1982; Schutz et aI. , 1982; Huang and Rorstad, 1983; Shimizu, 1983) .
DISCUSSION
Adenosine and its analogues are known to en hance the activity of adenylate cyclase in isolated Values are means ± SEM of specific [3H]NECA binding of the number of observations in parentheses. Concentration of [3H]NECA in the incubation medium was between 80 and 100 nM. Nonspecific binding determined using 200 flM L-phenylisopropyladenosine was �50% at these concentrations of [3H]NECA. CHA, cyciohexyladenosine; NEM, N-ethylmaleimide. cerebral microvessels (Huang and Drummond, 1979; Palmer and Ghai, 1982; Schutz et aI. , 1982; Huang and Rorstad, 1983; Shimizu, 1983) , which suggests the existence of A2-receptors in cerebral microvessels, but does not provide much informa tion regarding A)-receptors. Using ligand binding techniques, Palmer and Ghai (1982) found specific [3H]2-CA binding to rat cerebral microvessels, but their finding also does not distinguish between A) and A2-receptors because 2-CA shows affinity for the two adenosine receptor subtypes (Daly, 1982) . IC50 values for displacement of specific [3H)NECA binding from cerebral microvessels are the means of three to five deter minations, with the range in parentheses. Concentration of PH)NECA used in these experiments was 80-90 nM. Hill coeffi cients were determined as described by Bennett and Yamamura (1985) . NCPCA, 5' -N-cyclopropylcarboxamide adenosine; 2-CA, 2-chloroadenosine; L-PIA, L-phenylisopropyladenosine; CHA, cyclohexyladenosine; 8-PT, 8-phenyltheophylline; lBMX, 3-isobutyl-I-methylxanthine.
J Cereb Blood Flow Metab, Vol. 6. No.4, /986 Schutz et al. (1982) attempted to assess A2-re ceptors in rat cerebral microvessels by [3H]NECA binding studies and concluded that direct identifi cation of A2-receptors by this method was not pos sible owing to methodological limitations. Our re sults provide definitive information that indicates that there are few, if any, A)-receptors in rat and pig cerebral microvessels or choroid plexus, as deter mined by [3H]CHA and [3H]L-PIA binding and cy clic AMP generation studies. The few A) binding sites that we detect may not exist on cerebral mi crovessels, but could be due to the contamination of the microvessel preparations with neuronal and/ or glial elements, especially in the pig.
Studies of Az-receptors by specific NECA binding were more complicated, because although NECA is probably one of the best available ligands, it does not exhibit complete specificity for A2-re ceptors (Yeung and Green, 1984) . The interaction between NECA and A)-receptors was minimized by a variety of methods that yielded comparable re sults (Table 2) . Anyway, the problem of the mixed affinity of NECA to A)-and Az-receptor subtypes is not important in the case of cerebral micro vessels and choroid plexus, because of the virtual absence of A)-receptors in these tissues. Consistent with the results of adenylate cyclase studies, the finding of specific binding of [3H]NECA to cerebral microvessels and choroid plexus strongly suggests the presence of A2-receptors in these preparations. The specific binding of [3H]NECA was saturable but yielded curvilinear Scatchard plots that are best explained by the presence of two A2-receptor binding sites (Fig. 2, inset) . Two NECA binding sites, with Kd values similar to those we report here, have previously been described in rat liver (Schutz et aI. , 1982) and in human platelets (Hutte mann et aI. , 1984) . The low-affinity binding sites could be masked by L-PIA ( Fig. 3) , in agreement with the results of Yeung and Green (1984) .
Biological relevance of [3H]NECA binding to ce rebral microvessels was conferred by studying the ability of adenosine analogues and methylxanthines to displace specific [3H]NECA binding (IC50) and correlating these results with the known effects of these agents on cyclic AMP generation in cerebral microvessels and other tissues ( Table 4 ). The corre lation was excellent for adenosine agonists, but not entirely compatible in the case of the antagonists (Huang and Drummond, 1979; Schutz et aI. , 1982; Daly, 1983; Huang and Rorstad, 1983; Huttemann et aI. , 1984; Ukena et aI. , 1984) . In particular, 8-PT was not as potent in displacing [3H]NECA binding (an IC50 of 40 /-LM) as it was in blocking adenylate cyclase stimulation by NECA in cerebral micro-vessels (Schutz et al., 1982) and in other tissues (Daly, 1983) . The reason for this discrepancy is not clear, although it was noted that the blocking effect of methylxanthines on adenylate cyclase stimula tion in cerebral microvessels is less than that in other tissues (Shimizu, 1983) . It is also possible that NECA may bind to a membrane component other than the A2-receptor site.
Guanine nucleotides are known to decrease the specific binding of agonists to receptors that are positively coupled to adenylate cyclase activity (Limbird, 1981; Cooper, 1982) . Furthermore, the stimulatory actions of 2-CA (Huang and Drum mond, 1979) and NECA (Schutz et al., 1982) on ad enylate cyclase in cerebral microvessels are depen dent on the presence of GTP. Our results, showing that specific NECA binding to cerebral micro vessels is not appreciably affected by GTP or by its synthetic analogue, Gpp(NH)p, do not support this general rule. Yeung and Green (1984) reported that guanine nucleotides decrease the affinity of binding and increase the density of NECA receptor sites in striatal membranes. On the other hand, Huttemann et al. (1984) showed no effect of guanine nucleo tides on NECA binding to platelets at ligand con centrations that were similar to those used by Yeung and Green (1984) . Also, we have no explana tion for the apparent inhibitory effects of Mg 2 + on the specific binding of [3H]NECA to preparations of the cerebral cortex.
In conclusion, our results suggest the virtual ab sence of Acreceptors in cerebral microvessels and choroid plexus. On the other hand, cerebral micro vessels and choroid plexus seem to have a high density of A2-receptors, similar to that of the cere bral cortex. f32-Adrenergic receptors, which are positively coupled to adenylate cyclase, are also present in cerebral microvessels (Harik et al., 1981) . Thus, the action of agonists on these two re ceptors in cerebral microvessels may be additive and complementary. Although existing evidence suggests that adenosine is an important modulator of the cerebral circulation, probably via its action on the smooth muscles of larger (resistance) blood vessels (Winn et al., 1981) , it is not yet known whether adenosine has any effect on the cerebral microcirculation. Our findings indicate the exis tence of a mechanism by which adenosine can in fluence the physiology and/or pathophysiology of the cerebral microcirculation and choroid plexus. Such influence, yet uncovered, may result in alter ations in the blood-brain barrier permeability to a variety of micro-and macromolecules and in changes in the rate of formation and the composi tion of cerebrospinal fluid.
